TP-1287

N/A

Report date: 2024/03/13 20:05:28
NME

Base Information

Drug NameTP-1287
Drug Alias NameTP-1287
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsSolid tumoursSarcomaSarcoma, Synovial +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTolero Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Pharma America Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursSarcomaSarcoma, Synovial +[5] 

Other Information

ATC CodeN/A
Related LinksN/A